Overall demand for cardiovascular services has been declining by about 3 percent per year for the past several years, but HCA said this heightened trend is what impacted its markets. Overall, the decline in the Medicare case mix index resulted in a $28 million adverse impact. Other drivers of HCA’s CMI decline included a decline within medical cases and a new CMS grouper effective Oct. 2010.
However, HCA confirmed 2011 guidance of 3 to 5 percent growth in its adjusted earnings before interest, taxes, depreciation and amortization, assuming it substantially meets HITECH reimbursement parameters.
Related Articles on HCA:
291 Hospital and Health System Leaders to Know
HCA, Adventist Health Opening Two Hospitals in Florida
Reductions in Florida’s Medicaid Program Could Cost HCA $50M This Year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
